Table:
begin	end	state
1	20	cytoplasmic
21	44	transmembrane
45	55	non-cytoplasmic
56	76	transmembrane
77	87	cytoplasmic
88	106	transmembrane
107	116	non-cytoplasmic
117	134	transmembrane
135	145	cytoplasmic
146	170	transmembrane
171	175	non-cytoplasmic
176	195	transmembrane
196	254	cytoplasmic
255	274	transmembrane
275	286	non-cytoplasmic
287	310	transmembrane
311	317	cytoplasmic
318	336	transmembrane
337	341	non-cytoplasmic
342	365	transmembrane
366	383	cytoplasmic
384	404	transmembrane
405	409	non-cytoplasmic
410	429	transmembrane
430	447	cytoplasmic

Input:
>Pf1N1B4_2832 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_2832
MRKIDVHEVIDNARFNRFHWMVLFWCALIIIFDGYDLVIYGVVLPMLMKEWGLSPLQAGA
LGSYALFGMMFGALFFGPLSDKIGRKKAITLCVMLFSGFTVLNGFARNPTEFGLCRFIAG
LGIGGVMPNVVALMNEYAPKKIRSTLVAIMFSGYSVGGMLSAGLGIVLIPSFGWQSVFYV
AVLPLLLLPLIMYFLPESVGFMLRQGRNQEARNVLERVDPAYVALASDQLHMSEVKGTGT
PVLQLFREGRALRTLMLWLAFFCCLLMVYALSSWLPKLMANAGYSLGSSLSFLLVLNFGA
IFGAVGGGVLGDKLNLPRVLAVFFVVAAVSITLLGFNSPMPVLYLLIALAGATTIGSQIL
LYACAAQFYSMTIRSTGLGWASGIGRNGAIVGPLLGGALLGISLPLQLNFMAFALPGAVA
ALAMTVFAISSQRSAKGATQTLAPTSA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server